Skip to main content
. 2022 Mar 23;7:94. doi: 10.1038/s41392-022-00950-y

Fig. 6. Rationale underlying the design strategy of COVID-19 mRNA vaccine.

Fig. 6

Representation of the SARS-CoV-2 reference genome showing structural, nonstructural, and accessory proteins, consisting of ORF1a, ORF1b, Spike protein (S), ORF3a, ORF3b, Envelope (E), Membrane (M), ORF6, ORF7a, ORF7b, ORF8, ORF9b, ORF14, Nucleocapsid (N) and ORF10.485 Spike and receptor-binding domain (RBD) proteins are mainly used as target antigens for the design and optimization of COVID-19 mRNA vaccines. This figure is created with BioRender.com